Interfering with Ras signaling using membrane-permeable peptides or drugs.
Maruta
Hiroshi
H
Tumor Suppressor Laboratory, Ludwig Institute for Cancer Research, Melbourne, Australia.
He
Hong
H
Nheu
Thao
T
D016475:3T3 Cells; D000595:Amino Acid Sequence; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002352:Carrier Proteins / Q000378:metabolism; D002463:Cell Membrane Permeability; D002471:Cell Transformation, Neoplastic; D057846:Cell-Penetrating Peptides; D005260:Female; D006801:Humans; D051379:Mice; D008819:Mice, Nude; D008969:Molecular Sequence Data; D010455:Peptides / Q000494:pharmacology*; D011993:Recombinant Fusion Proteins; D015398:Signal Transduction / Q000187:drug effects*; D020764:cdc42 GTP-Binding Protein / Q000378:metabolism; D018631:ras Proteins / Q000037:antagonists & inhibitors*
D000970:Antineoplastic Agents; D002352:Carrier Proteins; D057846:Cell-Penetrating Peptides; D010455:Peptides; D011993:Recombinant Fusion Proteins; C414409:penetratin; D020764:cdc42 GTP-Binding Protein; D018631:ras Proteins